(Reuters) - U.S. healthcare conglomerate Johnson & Johnson is expected to announce a $21.5 billion deal to buy Swiss medical device maker Synthes Inc on Wednesday, the Wall Street Journal said, citing people familiar with the matter.
Reuters: Top News, Reuters
Tue, 04/26/2011 - 10:26pm
(Reuters) - U.S. healthcare conglomerate Johnson & Johnson is expected to announce a $21.5 billion deal to buy Swiss medical device maker Synthes Inc on Wednesday, the Wall Street Journal said, citing people familiar with the matter.